Medico Remedies Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹71.44
- Today's High:
- ₹74.9
- Open Price:
- ₹74.44
- 52W Low:
- ₹17.13
- 52W High:
- ₹100.79
- Prev. Close:
- ₹75.19
- Volume:
- 13057
Company Statistics
- Market Cap.:
- ₹6.44 billion
- Book Value:
- 71.98
- Revenue TTM:
- ₹1.40 billion
- Operating Margin TTM:
- 4.91%
- Gross Profit TTM:
- ₹202.85 million
- Profit Margin:
- 5.16%
- Return on Assets TTM:
- 5.27%
- Return on Equity TTM:
- 17.84%
Company Profile
Medico Remedies Ltd had its IPO on under the ticker symbol MEDICO.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Medico Remedies Ltd has a staff strength of 0 employees.
Stock update
Shares of Medico Remedies Ltd opened at ₹74.44 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹71.44 - ₹74.9, and closed at ₹74.69.
This is a -0.67% slip from the previous day's closing price.
A total volume of 13,057 shares were traded at the close of the day’s session.
In the last one week, shares of Medico Remedies Ltd have slipped by -5.28%.
Medico Remedies Ltd's Key Ratios
Medico Remedies Ltd has a market cap of ₹6.44 billion, indicating a price to book ratio of 13.5491 and a price to sales ratio of 4.0536.
In the last 12-months Medico Remedies Ltd’s revenue was ₹1.40 billion with a gross profit of ₹202.85 million and an EBITDA of ₹96.20 million. The EBITDA ratio measures Medico Remedies Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Medico Remedies Ltd’s operating margin was 4.91% while its return on assets stood at 5.27% with a return of equity of 17.84%.
In Q1, Medico Remedies Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a negative 13.3%.
Medico Remedies Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 89.2414
- PEG
Its diluted EPS in the last 12-months stands at ₹0.87 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Medico Remedies Ltd’s profitability.
Medico Remedies Ltd stock is trading at a EV to sales ratio of 4.1382 and a EV to EBITDA ratio of 48.6812. Its price to sales ratio in the trailing 12-months stood at 4.0536.
Medico Remedies Ltd stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹874.48 million
- Total Liabilities
- ₹415.23 million
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Medico Remedies Ltd ended 2024 with ₹874.48 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹874.48 million while shareholder equity stood at ₹438.43 million.
Medico Remedies Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹415.23 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹9.11 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹2.47 million.
Medico Remedies Ltd’s total current assets stands at ₹645.39 million while long-term investments were ₹0 and short-term investments were ₹12.84 million. Its net receivables were ₹360.95 million compared to accounts payable of ₹309.86 million and inventory worth ₹196.99 million.
In 2024, Medico Remedies Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Medico Remedies Ltd paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹74.69
- 52-Week High
- ₹100.79
- 52-Week Low
- ₹17.13
- Analyst Target Price
- ₹
Medico Remedies Ltd stock is currently trading at ₹74.69 per share. It touched a 52-week high of ₹100.79 and a 52-week low of ₹100.79. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹77.8 and 200-day moving average was ₹74.24 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 8512.1% of the company’s stock are held by insiders while 177.5% are held by institutions.
Frequently Asked Questions About Medico Remedies Ltd
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Medico Remedies Limited manufactures and sells pharmaceutical formulations in India. The company offers antibiotics and anti-infective drugs; antipyretic, analgesic, and NSAIDs medicines; cardiovascular products; beta-lactams, penicillins, and cephalosporins; antidepressants, antipsychotics, and anti-epileptics; syrups; vitamins and supplements; antacid and anti-ulcer drugs; dry syrups; antifungals; pharmaceutical tablets; anti-diabetics; antimalarial medicines; ointments and creams; and miscellaneous products. It primarily exports its products to Venezuela, Cameroon, Guinea, Papua New Guinea, and Libya. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.